Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01E OTHER CARDIAC PREPARATIONS
C01EB Other cardiac preparations
C01EB25 Acoramidis
D11973 Acoramidis hydrochloride (JAN/USAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D11973 Acoramidis hydrochloride (JAN/USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG03143 Acoramidis
D11973 Acoramidis hydrochloride
DG03188 UGT1A9 substrate
DG03143 Acoramidis
D11973 Acoramidis hydrochloride
DG03190 UGT2B7 substrate
DG03143 Acoramidis
D11973 Acoramidis hydrochloride
Target-based classification of drugs [BR:br08310]
Transporters
Other transporters
Others
TTR
D11973 Acoramidis hydrochloride (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11973
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11973
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11973
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11973
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11973
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG03143 Acoramidis
DG03188 UGT1A9 substrate
DG03143 Acoramidis
DG03190 UGT2B7 substrate
DG03143 Acoramidis